Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study - Harbeck, N; Rastogi, P; Martin, M; monarchE Committee Members (Ann Oncol, 2021)
et al.